CPP’s pharmaco-prevention approach has been used with success in other disease categories such as cardiovascular, neuromuscular, and infectious disease but has yet to be applied to cancer.
Cancer Prevention Pharmaceuticals, Inc. is developing novel therapeutic agents that make possible the treatment of risk factors for cancer. Our clinical focus is in familial adenomatous polyposis, the prevention of recurrence in colon cancer survivors, neuroblastoma and other cancers.
Coal mining lore has it that canaries provided an early warning system to coal miners prior to the advent of sophisticated ventilation systems. Miners brought canaries into mine shafts to serve as a detection system. When the canaries stopped singing and fell off their perch that alerted the miners that gas levels in the mines were high and the miners had to evacuate before they were overcome with noxious fumes. The canaries provided the miners with protection before it was too late. That is where Cancer Prevention Pharmaceutical’s philosophy and the canary’s ability to save lives intersect. CPP seeks to identify and treat cancer precursors before the cancer has a chance to take hold. We are to cancer what canaries were to miners.